Sort
82,697 grants matching “vaccine development”
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors
$1,092,667Hildegund C. J. Ertl · Wistar Institute · U19 · FY2011 · AI
Medical Scientist Training Program
$1,092,400Terence S. Dermody · Vanderbilt University · T32 · FY2012 · GM
Malaria Parasite Ligands And Host Cell Receptors
$1,092,399Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Project 1: Panbetacoronavirus vaccines
$1,092,131Barton F Haynes · Duke University · P01 · FY2023 · AI
Impact of gene-drive systems for population modification on malaria vector mosquitoes
$1,092,110Anthony A James · University Of California-Irvine · R01 · FY2023 · AI
Preclinical evaluation of a trivalent Marburg vaccine
$1,092,086John Y Dong · Genphar, Inc. · U01 · FY2007 · AI
Vaccine Discovery for Chagas Disease
$1,091,483University Of Georgia (Uga) · P01 · FY2005 · AI
RI-Center for Clinical and Translational Science
$1,091,210Sharon Irene Smith Rounds · Brown University · U54 · FY2021 · GM
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
$1,091,199Elizabeth L Travis · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA
UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
$1,091,199Sharon Hermes Giordano · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
Directing Tumor-specific T cells to Tumors
$1,091,197Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma
$1,091,124Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2024 · AI
Malaria Vaccine Trials in Mali
$1,090,936Christopher V. Plowe · University Of Maryland Baltimore · U19 · FY2007 · AI
Lactobacilli as a Delivery Vehicle for Microbicides
$1,090,934Osel, Inc. · U19 · FY2004 · AI
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
$1,090,934Matthias Johannes Schnell · Thomas Jefferson University · R01 · FY2016 · AI
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,090,780Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Epitope Driven HIV Vaccine Development
$1,090,484Brown University · R01 · FY2004 · AI
Vector Production Core
$1,090,470Norman L Letvin · Duke University · U19 · FY2007 · AI
Universal room temperature stable influenza nanovaccine
$1,090,313Balaji Narasimhan · Iowa State University · R01 · FY2022 · AI
Immune Regulation in Mycobacterial and Fungal Infections
$1,089,788Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies
$1,089,767Laurent Karl Verkoczy · Applied Biomedical Science Institute · R01 · FY2022 · AI
Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS
$1,089,572Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
PREVENTION OF MATERNAL AND CONGENITAL CMV INFECTION
$1,089,568University Of Alabama At Birmingham · P01 · FY2000 · AI
High throughput NAPPA-proteoimmunomics and Vibrio cholerae vaccine development
$1,089,549Edward T. Ryan · Massachusetts General Hospital · U01 · FY2012 · AI
Plant Viruses as Platforms for Biomaterials
$1,089,392Scripps Research Institute · R01 · FY2002 · EB